Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection.
Saved in:
| Title: | Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection. |
|---|---|
| Authors: | Tut G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. g.tut@bham.ac.uk., Lancaster T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Butler MS; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Sylla P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Spalkova E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Bone D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Kaur N; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Bentley C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Amin U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Jadir AT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Hulme S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Ayodel M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Dowell AC; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Pearce H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Zuo J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Margielewska-Davies S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Verma K; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Nicol S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Begum J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Jinks E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Tut E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Krutikov M; UCL Institute of Health Informatics, London, UK., Shrotri M; UCL Institute of Health Informatics, London, UK., Giddings R; UCL Institute of Health Informatics, London, UK., Azmi B; UCL Institute of Health Informatics, London, UK., Fuller C; UCL Institute of Health Informatics, London, UK., Irwin-Singer A; Department of Health and Social Care, London, UK., Hayward A; Health Data Research UK, London, UK., Copas A; UCL Institute for Global Health, London, UK., Shallcross L; UCL Institute of Health Informatics, London, UK., Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. p.moss@bham.ac.uk. |
| Source: | Nature aging [Nat Aging] 2022 Jun; Vol. 2 (6), pp. 536-547. Date of Electronic Publication: 2022 May 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group US Country of Publication: United States NLM ID: 101773306 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-8465 (Electronic) Linking ISSN: 26628465 NLM ISO Abbreviation: Nat Aging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
